Cellebrite DI Ltd. (CLBT)
NEUTRALファンダメンタル
68
株価
$11.29
時価総額
$2.84B
パート1 · 企業の価値
概要
Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency. It also offers Inseyets, digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations; Guardian Forensics, an evidence management solution which enables customers to manage their digital forensics workflows, and to store, share and review digital evidence; Guardian Collaborate, a digital evidence sharing tool; and Guardian Investigate, a case management and AI-powered analytics solution. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence and enables actionable insights into a range of crime types; Corellium Falcon for conducting mobile vulnerability research, exploit introspection, and malware analysis; and Corellium Viper for mobile application penetration testing capabilities. Further, the company offers professional services, such as training and certification services, and advanced services. It serves federal, state, and local agencies, as well as corporations and service providers. The company is headquartered in Petah Tikva, Israel.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
No editorial profile for this company yet
No competitor list for this company yet.
貸借対照表と流動性
売上高
$496M
直近12か月(2026/3/31まで)
純利益
$72M
直近12か月(2026/3/31まで)
フリーキャッシュフロー
$125M
自己資本合計
$538M
負債合計
$23M
流動比率
1.62
利払い倍率
-
負債/EBITDA
0.30
一株当たり利益(EPS)
売上高と純利益
フリーキャッシュフロー
収益内訳
財務推移表
利益率の推移
負債の推移
負債の重さ
成長率グリッド
成長率 — 売上高
適正価値の推定
適正価値
$19.57
現在株価
$11.29
安全マージン
+42.3%
適正価値レンジ
$12.72 - $26.42
推定方法
バリュエーション指標
P/E レシオ
49.22
ROE
12.4%
P/B レシオ
5.27
P/FCF
22.72
粗利益率
83.0%
ROIC
3.8%
収益性レーダー
Value Creation (Economic Moat)
ROIC
3.8%
WACC
10.6%
ROIC − WACC
-6.7 pp
ROIC is below the cost of capital — the company is destroying value for every dollar invested.
ファンダメンタル分析基準
合格(13)
- Gross Margin 83.0%
- P/FCF 22.72
- Debt/Equity ratio
- Positive Free Cash Flow
- Current Ratio
- Debt/EBITDA
- ROE 15.5%
- Revenue Growth 5Y 19.5%
- Analyst Consensus 93% Buy
- Earnings Surprise avg 6.8%
- PEG Ratio 0.63
- Earnings Quality (OCF/NI) 2.01
- Net Margin Trend 16.5% vs -70.5%
不合格(6)
- Price CAGR 0.81%
- ROIC 3.8%
- P/B Ratio 5.27
- CapEx intensity
- DCF valuation (Overvalued)
- Piotroski F-Score 2/9
データなし(8)
- EPS data insufficient
- Dividend Payout NaN%
- Operating Margin NaN%
- Interest Coverage
- Return on Tangible Assets
- Low reliance on intangibles
- Price below Graham Number
- Share Dilution (missing shares data)
Piotroski F-スコア
重大な財務上の懸念
利益の質
高品質:利益はキャッシュに裏付けられている
株式希薄化
株式を買い戻している。株主に友好的
ガバナンス
パート2 · 株価と買い時
この部分は企業に価値があるかを判断するものではありません。ファンダメンタルズに納得したうえで、いつ買うかを選ぶためのものです。内容:テクニカル分析、ポテンシャル、過去のドローダウン、ガンマエクスポージャー。
Latest News
Recent headlines for CLBT, sourced from Markets Gazette.